BRCA1 and breast cancer: Here we show that the combination of Mps1 inhibitors and docetaxel leads to tumour cell death by elevating the levels of CIN, as evidenced by an increase in multipolar cell divisions, enhanced chromosome copy number variations and an increase in nuclear pleomorphism in BRCA1−/−;TP53−/− mammary tumours.